• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro (CAS No. 198895-50-0): A Versatile Scaffold in Modern Pharmaceutical Research

Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro (CAS No. 198895-50-0) is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry due to its unique structural features and biological activities. This aromatic molecule belongs to the imidazopyridine class, a scaffold that has been extensively explored for its potential in drug discovery. The presence of a chloro substituent at the 5-position and an aldehyde group at the 3-position enhances its reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active compounds.

The chemical structure of Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro features a fused ring system consisting of an imidazole ring and a pyridine ring. This fused system contributes to its stability and allows for multiple points of functionalization, which is crucial for medicinal chemists aiming to develop novel therapeutic agents. The aldehyde functionality at the 3-position serves as a reactive handle for further derivatization, enabling the formation of amides, imines, and other important pharmacophores.

In recent years, there has been a surge in research focused on developing new treatments for various diseases, including cancer, infectious diseases, and neurological disorders. Imidazo[1,2-a]pyridine derivatives have emerged as promising candidates due to their ability to interact with multiple biological targets. Specifically, studies have shown that compounds containing the imidazopyridine scaffold can exhibit inhibitory activity against kinases, which are key enzymes involved in cell signaling pathways. The 5-chloro substituent in Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro (CAS No. 198895-50-0) has been found to enhance binding affinity to these targets, potentially leading to more effective drug candidates.

One of the most compelling aspects of this compound is its role as a building block in the synthesis of small-molecule inhibitors. Researchers have leveraged its structural versatility to develop molecules that target specific disease-related proteins. For instance, studies have demonstrated that derivatives of Imidazo[1,2-a]pyridine-3-carboxaldehyde can inhibit the activity of Janus kinases (JAKs), which are overexpressed in certain types of leukemia and autoimmune diseases. The chloro group plays a critical role in modulating the electronic properties of the molecule, thereby influencing its binding interactions with biological targets.

The synthesis of Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro (CAS No. 198895-50-0) involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include cyclization reactions followed by functional group transformations such as chlorination and formylation. Advances in synthetic methodologies have enabled researchers to produce this compound more efficiently, making it more accessible for further medicinal chemistry applications.

Recent publications have highlighted the use of Imidazo[1,2-a]pyridine derivatives in preclinical studies aimed at evaluating their therapeutic potential. These studies have shown promising results in terms of efficacy and safety profiles. For example, certain derivatives have demonstrated antitumor activity by inhibiting the growth of cancer cells through mechanisms such as induction of apoptosis and inhibition of angiogenesis. The impressive biological activity observed with these compounds underscores their significance as lead structures for drug development.

The pharmacokinetic properties of Imidazo[1,2-a]pyridine-3-carboxaldehyde, 5-chloro (CAS No. 198895-50-0) and its derivatives are also subjects of intense investigation. Understanding how these molecules are absorbed, distributed, metabolized, and excreted is crucial for optimizing their clinical use. Computational modeling techniques have been employed to predict pharmacokinetic profiles based on structural features, which helps guide the design of more effective drug candidates.

In conclusion, Imidazo[1,2-a]pyridine-3-carboxaldehyde (CAS No. 198895-50-0) is a versatile scaffold with significant potential in pharmaceutical research. Its unique structural features and reactivity make it an invaluable intermediate for synthesizing novel therapeutic agents targeting various diseases. The current research landscape suggests that this compound will continue to play a crucial role in drug discovery efforts aimed at improving human health.

• 29096-59-1(6-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde)
• 497058-00-1(3-CHLOROIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE)
• 885275-55-8(5-Chloro-2-methyl-imidazo1,2-apyridine-3-carboxylic Acid)
• 1268520-94-0(5-chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1000017-93-5(5-Chloroimidazo1,2-apyridine-2-carboxylic Acid)
• 728864-61-7(6-Chloro-2-methylimidazo[1,2-a]pyridine-3-carbaldehyde)
• 131773-23-4(2-Chloroimidazo[1,2-a]pyridine-3-carbaldehyde)
• 131773-22-3(2,6-dichloro-Imidazo[1,2-a]pyridine-3-carboxaldehyde)
• 141517-47-7(5-Chloro-2-methylimidazo1,2-apyridine)
• 881841-35-6(5-chloro-Imidazo[1,2-a]pyridine-2-carboxaldehyde)